期刊文献+

多西紫杉醇联合顺铂和5-氟尿嘧啶治疗晚期胃癌的疗效观察 被引量:3

Clinical observation of patients with advanced gastric cancer treated with docetaxel combined with cisplatin and 5-fluorouracil
暂未订购
导出
摘要 目的观察多西紫杉醇联合顺铂和5-氟尿嘧啶治疗晚期胃癌的临床疗效。方法选取2010年2月~2012年2月于笔者所在医院接受检查和治疗的晚期胃癌患者48例,随机分为观察组与对照组,每组24例,观察其治疗总有效率。结果观察组患者的治疗总有效率为54.17%,明显高于对照组的33.34%,两组比较差异有统计学意义(P<0.05)。结论多西紫杉醇联合顺铂和5-氟尿嘧啶的临床治疗效果显著,值得推广。 Objective To observe the clinical effects of patients with advanced gastric cancer treated with docetaxel combined with cisplatin and 5-fluorouracil.Methods 48 patients with gastric cancer in the author’s hospital were randomly divided into two groups,and each had 24 patients.The clinical effects were analyzed.Results The total effective rate of the observation group was 54.17%,and obviously more than that of control group(P 〈 0.05).Conclusion Docetaxel combined with cisplatin and 5-fluorouracil which were used in treating gastric cancer has a good clinical effect and the treatment is worthy of promotion.
作者 吴平利
出处 《中国医药科学》 2012年第15期60-61,共2页 China Medicine And Pharmacy
关键词 多西紫杉醇 顺铂 5-氟尿嘧啶 晚期胃癌 Docetaxel Cisplatin 5-fluorouracil Advanced gastric cancer
  • 相关文献

参考文献6

二级参考文献44

  • 1冯继锋,陆建伟,孙小峰.氟尿嘧啶/亚叶酸钙+紫杉醇联合化疗双周方案治疗晚期胃癌[J].癌症,2004,23(12):1704-1706. 被引量:14
  • 2陈绍水,宁方玲,吕俊华,赵磊,于泽顺,彭宪忠.多西他赛联合顺铂、5-Fu治疗晚期胃癌近期疗效分析[J].现代肿瘤医学,2005,13(5):658-659. 被引量:12
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 4Wagner AD, Grothe W, Behl S, et al. Chemotherapy for advanced gastric cancer [ J ]. Cochrane Database Syst Rev,2005,18 (2) :4 - 64.
  • 5Roth AD, Maibach R, Martinelli G, et al. Docetaxel (Taxotere) - cisplatin (TC) :an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK) ,and the European institute of Oncology (EIO) [ J ]. Ann Oncol,2000,11 (3) : 301 - 306.
  • 6Constenla M, Garcia -Arroyo R, Lorenzo I, et al. Docetaxel,5 -fluorouraeil, and leucovorin as treatment for advanced gastric cancer: results of a phase Ⅱ study[ J ]. Gastric Cancer,2002,5 ( 3 ) : 142 - 147.
  • 7Oh DY, Kim TY, Kwon JH, et al. Docetaxel + 5 - fluorouraeil + cisplatin 3 - day combination chemotherapy as a first - line treatment in patients with unreseetable gastric cancer [ J ]. Jpn J Clin Oncol,2005,35 (7) :380 - 385.
  • 8Roth AD, Mailbach R, Falk S, et al. Docetaxel - cisplatin - 5 - FU ( TCF ) versus docetaxel cisplatin (TC) versus epirubicin cisplatin 5 - FU (ECF) as systemic treatment for advanced gastric carcinoma (AGC) : a randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK) [ J ]. J Clin Oncol, 2004,22 (12) :318.
  • 9Ajani JA, FodorMB, Tjulandin SA, et al. Phase Ⅱ multi - institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma [ J ]. J Clin Oncol,2005,23 ( 24 ) : 5660 - 5667.
  • 10Ajani JA, Van Cutsem E, Moiseyenko V, et al. Docetaxel, cisplatin, 5 - fluorouracil compared to cisplatin and 5 -fluorouracil for chemotherapy- naive patients with metastatic or locally recun'ent,unresectable gasUic carcinoma:interim results of a randomized phase Ⅲ trial ( V325 ) (abstr) [ J]. Proc Am Soc Clin Oncol,2003,22:249.

共引文献28

同被引文献19

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部